CRANBURY, N.J.--(BUSINESS WIRE)--Healthcare Analytics News™ (HCA), a premier media platform that covers medicine and healthcare technology and is the official publication of Healthcare Research and Analytics (HRA®), explored the future of individualized care in oncology in a recent article.
The article discussed industry’s dependence on International Classification of Diseases codes, which often lack specificity and highlights the future of precision medicine using Cota Nodal Address (CNA), which offers effortless methods to conduct significant analytics. To provide precise results, CNA sorts patients by 6 codes: cancer type, neoplasm, invasive ductal, phenotype, advancement therapy and number of progressions.
“As precision medicine continues to prove effective, it will likely become something of a norm. In fact, soon enough, doctors might be committing malpractice if they were to treat cancer without considering phenotypes, pathologies and genetics,” said Andrew Norden, M.D., Cota chief marketing officer.
Additionally, the article highlights Hackensack Meridian Health in New Jersey, which has included this strategy in their payment plans for 6 or 12 months of cancer care to offer convenient and precise care to their patients. Because of the richness of the data that we provide and the use of the CNA to organize that data, both organizations know what costs to expect,” Norden said about the partnership. He further explained that the partnership offers a “granular ability to ensure that the optimal therapies are chosen to achieve the best possible outcomes and to minimize toxicities all while controlling costs.”
For more information, visit www.hcanews.com.
About Healthcare Analytics News™:
Healthcare Analytics News™ (HCA) covers the nexus of medicine and technology. A comprehensive resource for key healthcare decision-makers and physicians, HCA provides real-time news and insight on data analytics, population health management, telehealth and how new technology can improve patient outcomes. For more information, visit http://www.hcanews.com.
About HRA®:
HRA® – Healthcare Research & Analytics is a consultative healthcare market research practice combining the power of Michael J. Hennessy Associates, Inc. and a team of highly experienced market research professionals who have a passion for uncovering insights for clients across the pharmaceutical, biotech and medical device markets. For more information, visit http://www.hraresearch.com.
